Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BETHANY LUCAS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1477792489
CMS profile
1174219
Location
EDGEWOOD, KY

General Payments · PY2019–2024

$711.91

  • Reported across 40 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$649.67

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $649.67 39

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $212.88 14
Lilly USA, LLC $96.70 6
AIMMUNE THERAPEUTICS, INC. $59.02 4
Novo Nordisk AS $53.75 3
PFIZER INC. $52.14 3
Acerta Pharma LLC $45.30 3
SHIELD THERAPEUTICS INC $32.88 1
Astellas Pharma US Inc $26.52 1
Esperion Therapeutics, Inc. $25.82 1
DEXCOM, INC. $17.50 1
Amgen Inc. $13.99 1
GlaxoSmithKline, LLC. $13.17 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $62.24 1
PY2024 $649.67 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $11.52 04/27/2024 Food and Beverage Undisputed 01/23/2026 1104908082 CMS
ABBVIE INC. $3.06 05/16/2024 Food and Beverage Undisputed 01/23/2026 1104908084 CMS
ABBVIE INC. $8.50 06/27/2024 Food and Beverage Undisputed 01/23/2026 1104908086 CMS
ABBVIE INC. $33.43 07/03/2024 Food and Beverage Undisputed 01/23/2026 1104908088 CMS
ABBVIE INC. $13.98 07/24/2024 Food and Beverage Undisputed 01/23/2026 1104908090 CMS
ABBVIE INC. $18.25 07/29/2024 Food and Beverage Undisputed 01/23/2026 1104908092 CMS
ABBVIE INC. $19.71 08/13/2024 Food and Beverage Undisputed 01/23/2026 1104908094 CMS
ABBVIE INC. $10.05 08/20/2024 Food and Beverage Undisputed 01/23/2026 1104908096 CMS
ABBVIE INC. $16.71 08/27/2024 Food and Beverage Undisputed 01/23/2026 1104908098 CMS
ABBVIE INC. $21.45 10/09/2024 Food and Beverage Undisputed 01/23/2026 1104908100 CMS
ABBVIE INC. $8.80 10/28/2024 Food and Beverage Undisputed 01/23/2026 1104908102 CMS
ABBVIE INC. $15.11 11/19/2024 Food and Beverage Undisputed 01/23/2026 1104908104 CMS
ABBVIE INC. $19.18 11/26/2024 Food and Beverage Undisputed 01/23/2026 1104908106 CMS
ABBVIE INC. $13.13 12/11/2024 Food and Beverage Undisputed 01/23/2026 1104908108 CMS
AIMMUNE THERAPEUTICS, INC. $13.30 07/25/2024 Food and Beverage Undisputed 01/23/2026 1146971225 CMS
AIMMUNE THERAPEUTICS, INC. $14.04 10/16/2024 Food and Beverage Undisputed 01/23/2026 1147000839 CMS
AIMMUNE THERAPEUTICS, INC. $17.81 11/21/2024 Food and Beverage Undisputed 01/23/2026 1147000923 CMS
AIMMUNE THERAPEUTICS, INC. $13.87 12/17/2024 Food and Beverage Undisputed 01/23/2026 1147000869 CMS
Amgen Inc. $13.99 10/23/2024 Food and Beverage Undisputed 01/23/2026 1111638392 CMS
Astellas Pharma US Inc $26.52 12/05/2024 Food and Beverage Undisputed 01/23/2026 1139439310 CMS
AstraZeneca Pharmaceuticals LP $14.57 06/20/2024 Food and Beverage Undisputed 01/23/2026 1104295712 CMS
AstraZeneca Pharmaceuticals LP $16.13 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105504646 CMS
AstraZeneca Pharmaceuticals LP $14.60 09/11/2024 Food and Beverage Undisputed 01/23/2026 1104423967 CMS
Dexcom, Inc. $17.50 09/17/2024 Food and Beverage Undisputed 01/23/2026 1153286252 CMS
Esperion Therapeutics, Inc. $25.82 08/07/2024 Food and Beverage Undisputed 01/23/2026 1129444718 CMS
GlaxoSmithKline, LLC. $13.17 09/20/2024 Food and Beverage Undisputed 01/23/2026 1116114948 CMS
Lilly USA, LLC $16.76 06/21/2024 Food and Beverage Undisputed 01/23/2026 1136013221 CMS
Lilly USA, LLC $16.42 07/26/2024 Food and Beverage Undisputed 01/23/2026 1136013219 CMS
Lilly USA, LLC $15.02 08/16/2024 Food and Beverage Undisputed 01/23/2026 1136068372 CMS
Lilly USA, LLC $18.06 09/25/2024 Food and Beverage Undisputed 01/23/2026 1136068368 CMS
Lilly USA, LLC $17.04 10/12/2024 Food and Beverage Undisputed 01/23/2026 1136068370 CMS
Lilly USA, LLC $13.40 11/08/2024 Food and Beverage Undisputed 01/23/2026 1136079723 CMS
Novo Nordisk Inc $18.18 09/06/2024 Food and Beverage Undisputed 01/23/2026 1097532001 CMS
Novo Nordisk Inc $19.74 12/13/2024 Food and Beverage Undisputed 01/23/2026 1097577644 CMS
Novo Nordisk Inc $15.83 12/19/2024 Food and Beverage Undisputed 01/23/2026 1097566407 CMS
PFIZER INC. $16.49 05/21/2024 Food and Beverage Undisputed 01/23/2026 1131817048 CMS
PFIZER INC. $13.31 07/30/2024 Food and Beverage Undisputed 01/23/2026 1131856114 CMS
PFIZER INC. $22.34 08/15/2024 Food and Beverage Undisputed 01/23/2026 1132035420 CMS
SHIELD THERAPEUTICS INC $32.88 11/08/2024 Food and Beverage Undisputed 01/23/2026 1150153266 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.